rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Raul R. Silva

EVP and CSO

Company insider

Files Form 4 as: EVP and CSO, Cingulate.

In numbers

Trades disclosed
36
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
7 Dec 2021
Last trade
30 Sep 2026
Last filed
2 Oct 2026

Companies traded

Where they are an officer
CING CingulateOfficer · Biotechnology · last 30 Sep 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
30 Sep 2026filed 2 Oct 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—4,293 at $0.00filing
16 Jul 2026filed 20 Jul 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—53,600 at $0.00filing
16 Jul 2026filed 20 Jul 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—26,400 at $0.00filing
16 Jul 2026filed 20 Jul 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—53,600 at $0.00filing
16 Jul 2026filed 20 Jul 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—26,400 at $0.00filing
30 Jun 2026filed 2 Jul 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—3,885 at $0.00filing
30 Jun 2026filed 2 Jul 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—3,885 at $0.00filing
31 Mar 2026filed 8 May 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—3,422 at $0.00filing
31 Mar 2026filed 8 May 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—3,422 at $0.00filing
9 Mar 2026filed 11 Mar 2026CING CingulateBiotechnologySEC FORM 4 Code A—4,526 at $0.00filing
9 Mar 2026filed 11 Mar 2026CING CingulateBiotechnologySEC FORM 4 Code F—1,828 at $0.00filing
9 Mar 2026filed 11 Mar 2026CING CingulateBiotechnologySEC FORM 4 Code A—4,526 at $0.00filing
9 Mar 2026filed 11 Mar 2026CING CingulateBiotechnologySEC FORM 4 Code F—1,828 at $0.00filing
31 Dec 2025filed 5 Jan 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—6,625 at $0.00filing
31 Dec 2025filed 5 Jan 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—6,625 at $0.00filing
30 Sep 2025filed 10 Nov 2025CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—7,334 at $0.00filing
7 Jul 2025filed 9 Jul 2025CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—51,500 at $0.00filing
30 Jun 2025filed 1 Jul 2025CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—1,000 at $0.00filing
31 Mar 2025filed 1 Jul 2025CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—1,000 at $0.00filing
18 Feb 2025filed 20 Feb 2025CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—17,630 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Bryan Wade DowneyEVP & Chief Commercial Officer · EVP & Chief Commercial Officer at Cingulate, filing Form 4 there in the last year
Shane J. SchafferChief Executive Officer · Chief Executive Officer at Cingulate, filing Form 4 there in the last year
Peter J. WerthDirector · Director at Cingulate, filing Form 4 there in the last year
Jennifer L. CallahanEVP and CFO · EVP and CFO at Cingulate, filing Form 4 there in the last year
Matthew BramsEVP and Chief Medical Officer · EVP and Chief Medical Officer at Cingulate, filing Form 4 there in the last year